Did you mean 2012 10 0?
Displaying drugs 1826 - 1826 of 1826 in total
Mapatumumab
Mapatumumab is under investigation in clinical trial NCT00094848 (Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-hodgkin's Lymphoma (NHL)).
Investigational
Displaying drugs 1826 - 1826 of 1826 in total